A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade
- PMID: 15485483
- DOI: 10.1111/j.1471-4159.2004.02737.x
A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade
Abstract
Accumulating evidence points to an important role of intraneuronal A beta as a trigger of the pathological cascade of events leading to neurodegeneration and eventually to Alzheimer's disease (AD) with its typical clinical symptoms, like memory impairment and change in personality. In the present article, we review recent findings on intracellular monomeric and oligomeric beta-amyloid (A beta) generation and its pathological function in cell culture, transgenic AD mouse models and post mortem brain tissue of AD and Down syndrome patients, as well as its interaction with oxidative stress and its relevance in apoptotic cell death. Based on these results, a modified A beta hypothesis is formulated, that integrates biochemical, neuropathological and genetic observations with AD-typical neuron loss and plaque formation.
Similar articles
-
Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.Neurosci Biobehav Rev. 2007;31(1):125-47. doi: 10.1016/j.neubiorev.2006.07.007. Epub 2006 Oct 20. Neurosci Biobehav Rev. 2007. PMID: 17055579 Review.
-
Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.Acta Neuropathol. 2008 Dec;116(6):647-55. doi: 10.1007/s00401-008-0451-6. Epub 2008 Oct 31. Acta Neuropathol. 2008. PMID: 18974993
-
Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.Neurodegener Dis. 2008;5(3-4):140-2. doi: 10.1159/000113684. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322372 Review.
-
Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.Genes Brain Behav. 2008 Feb;7 Suppl 1:6-11. doi: 10.1111/j.1601-183X.2007.00372.x. Genes Brain Behav. 2008. PMID: 18184366 Review.
-
Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.J Neurosci Res. 2008 May 15;86(7):1615-25. doi: 10.1002/jnr.21601. J Neurosci Res. 2008. PMID: 18189321
Cited by
-
Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity.PLoS Pathog. 2022 Nov 17;18(11):e1010929. doi: 10.1371/journal.ppat.1010929. eCollection 2022 Nov. PLoS Pathog. 2022. PMID: 36395147 Free PMC article. Review.
-
An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer's disease: pyroglutamate amyloid beta.Brain Commun. 2022 Feb 4;4(1):fcac022. doi: 10.1093/braincomms/fcac022. eCollection 2022. Brain Commun. 2022. PMID: 35479516 Free PMC article.
-
δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.Mol Psychiatry. 2021 Feb;26(2):586-603. doi: 10.1038/s41380-018-0286-z. Epub 2018 Oct 31. Mol Psychiatry. 2021. PMID: 30382187 Free PMC article.
-
Is there a primary role of the mitochondrial genome in Alzheimer's disease?J Bioenerg Biomembr. 2009 Oct;41(5):411-6. doi: 10.1007/s10863-009-9239-1. J Bioenerg Biomembr. 2009. PMID: 19798559 Review.
-
Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein.Int J Alzheimers Dis. 2011 Apr 12;2011:304583. doi: 10.4061/2011/304583. Int J Alzheimers Dis. 2011. PMID: 21547225 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical